Vascular Neurology Considerations for Anti-Amyloid Immunotherapy
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access.
Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
Authors Mark Fisher, MD and Steve Greenberg, MD announce the publication of the science advisory in the journal STROKE and discuss predictors of ARIA, the use of antithrombotic and thrombolytic medications in patients receiving anti-amyloid therapy, and suggested treatment approaches.
Recommended Videos
Stroke Risk Calculation and Shared Decision Making in the Management of At...
Key Takeaways and Limitations in Large-Core Ischemic Stroke Endovascular T...
Overview and Motivation Behind the 2024 Guideline for the Primary Preventi...
Traditional Risk Factors from the 2024 Guideline for the Primary Preventio...
Women and Pregnancy in the 2024 Guideline for the Primary Prevention of St...
Loading...
Save Video
Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
Video is not available. Please check the URL.